Chromatin modifying factors control radiation response and genomic stability

染色质修饰因子控制辐射反应和基因组稳定性

基本信息

  • 批准号:
    8920046
  • 负责人:
  • 金额:
    $ 31.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We identified a chromatin-modifying factor "hMOF", the human ortholog of the Drosophila MOF gene (Males absent On the First) that interacts with and regulates the ionizing radiation (IR) response function of ATM. hMOF is a member of the MYST family of histone acetyltransferases (HATs) and acetylates histone H4 at lysine 16 (H4K16ac). Histone H4K16ac is a unique histone modification that prevents higher order chromatin packing, which can impede protein access to DNA. Mammalian MOF impacts multiple points in the cellular DNA damage response (DDR) and double-strand break (DSB) repair pathways probably as a critical regulator of chromatin structure. This competing renewal brings together and expands insights gained during the previous funding period from two separate RO1's [R01CA123232 (not being renewed), R01CA129537 (this renewal)] that focused our attention on how MOF-dependent H4K16ac levels and the phosphorylation of MOF influence DNA DSB repair and oncogenesis, as we found that acetylation of histone H4 at K16 by MOF is an epigenetic signature of cellular proliferation common to both embryogenesis and oncogenesis. In addition, our results suggest that preexisting MOF-dependent H4K16ac may influence the DDR. However the precise effect of H4K16ac chromatin status as well as most other chromatin proteins/modifications on the DDR is largely unknown. A major impediment in the mammalian DNA repair field to answering this type of question has been the non-specificity of DNA damage inducing agents (for example: ionizing radiations), making it difficult to characterize how specific differences in chromatin environment impact DNA lesion signaling/repair. We will circumvent this problem by using site-specific repair systems to determine the role of histone H4K16ac in DSB repair. We have successfully generated a high-density genome wide map identifying H4K16ac rich or poor chromosomal sites. Utilizing this data, we will directly test the hypothesis that local H4K16ac levels on chromosomes regulate DDR. To examine sites with defined H4K16ac chromatin status, we will utilize zinc finger nucleases (ZFNs) to produce DSBs within regions we have identified as having high or low H4K16ac levels and determine the subsequent recruitment of DDR components. Furthermore, we have shown that MOF itself is phosphorylated at threonine 392 (MOF-T392) post irradiation in an ATM-dependent manner that is important for the DDR and cell survival. Therefore, to determine the role of ATM dependent MOF phosphorylation in signaling/repair protein recruitment, we will generate mutant MOF-phosphorylation (mMof- T392A) site knock-in mice and examine the DSB signaling/repair mechanism and consequences for genomic integrity and cancer development. This approach uniquely allows for the determination of how MOF-dependent local H4K16ac levels and MOF phosphorylation affect the DDR, repair pathway choice and oncogenesis.
描述(由申请人提供):我们鉴定了一种染色质修饰因子“hMOF”,它是果蝇MOF基因的人类直系同源物(雄性在第一次缺失),与ATM的电离辐射(IR)反应功能相互作用并调节其功能。hMOF是组蛋白乙酰转移酶(HAT)的MYST家族的成员,并且在赖氨酸16(H4 K16 ac)处乙酰化组蛋白H4。组蛋白H4 K16 ac是一种独特的组蛋白修饰,可以阻止高级染色质包装,这可能会阻碍蛋白质进入DNA。哺乳动物的MOF可能作为染色质结构的关键调节剂影响细胞DNA损伤反应(DDR)和双链断裂(DSB)修复途径中的多个点。此次竞争性更新将上一个资助期内从两个独立的RO 1 [R 01 CA 123232]中获得的见解结合在一起并加以扩展(未更新),R 01 CA 129537(这次更新)],使我们的注意力集中在MOF依赖性H4 K16 ac水平和MOF的磷酸化如何影响DNA DSB修复和肿瘤发生,因为我们发现组蛋白H4在K16处被MOF乙酰化是胚胎发生和肿瘤发生共同的细胞增殖的表观遗传标记。此外,我们的研究结果表明,预先存在的MOF依赖的H4 K16 ac可能会影响DDR。然而,H4 K16 ac染色质状态以及大多数其他染色质蛋白/修饰对DDR的精确影响在很大程度上是未知的。在哺乳动物DNA修复领域回答这类问题的主要障碍是DNA损伤诱导剂(例如:电离辐射)的非特异性,使得难以表征染色质环境中的特定差异如何影响DNA损伤信号传导/修复。我们将通过使用位点特异性修复系统来确定组蛋白H4 K16 ac在DSB修复中的作用来规避这个问题。我们已经成功地产生了一个高密度的全基因组图谱,识别H4 K16 ac丰富或贫穷的染色体位点。利用这些数据,我们将直接测试染色体上的局部H4 K16 ac水平调节DDR的假设。为了检查具有确定的H4 K16 ac染色质状态的位点,我们将利用锌指核酸酶(ZFN)在我们已经鉴定为具有高或低H4 K16 ac水平的区域内产生DSB,并确定DDR组分的后续募集。此外,我们已经表明,MOF本身在照射后以ATM依赖性方式在苏氨酸392(MOF-T392)处磷酸化,这对于DDR和细胞存活是重要的。因此,为了确定ATM依赖性MOF磷酸化在信号传导/修复蛋白募集中的作用,我们将产生突变的MOF磷酸化(mMof-T392 A)位点敲入小鼠,并检查DSB信号传导/修复机制以及对基因组完整性和癌症发展的后果。这种方法独特地允许确定MOF依赖性局部H4 K16 ac水平和MOF磷酸化如何影响DDR、修复途径选择和肿瘤发生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tej K Pandita其他文献

Tej K Pandita的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tej K Pandita', 18)}}的其他基金

Role of Heterochromatin protein 1 Beta in Genome Maintenance and Oncogenesis
异染色质蛋白 1 Beta 在基因组维护和肿瘤发生中的作用
  • 批准号:
    9091300
  • 财政年份:
    2014
  • 资助金额:
    $ 31.14万
  • 项目类别:
Role of Heterochromatin protein 1 Beta in Genome Maintenance and Oncogenesis
异染色质蛋白 1 Beta 在基因组维护和肿瘤发生中的作用
  • 批准号:
    8657357
  • 财政年份:
    2014
  • 资助金额:
    $ 31.14万
  • 项目类别:
Chromatin modifying factors control radiation response and genomic stability
染色质修饰因子控制辐射反应和基因组稳定性
  • 批准号:
    8869493
  • 财政年份:
    2014
  • 资助金额:
    $ 31.14万
  • 项目类别:
Tumor-cell-specific targets for combined hyperthermia and radiation effects
结合热疗和放射效应的肿瘤细胞特异性靶标
  • 批准号:
    8870039
  • 财政年份:
    2014
  • 资助金额:
    $ 31.14万
  • 项目类别:
Role of Heterochromatin protein 1 Beta in Genome Maintenance and Oncogenesis
异染色质蛋白 1 Beta 在基因组维护和肿瘤发生中的作用
  • 批准号:
    9309045
  • 财政年份:
    2014
  • 资助金额:
    $ 31.14万
  • 项目类别:
15th International Workshop on Ataxia-Telangiectasia and ATM to be held in India
第十五届共济失调毛细血管扩张和 ATM 国际研讨会将在印度举行
  • 批准号:
    8425174
  • 财政年份:
    2011
  • 资助金额:
    $ 31.14万
  • 项目类别:
15th International Workshop on Ataxia-Telangiectasia and ATM to be held in India
第十五届共济失调毛细血管扩张和 ATM 国际研讨会将在印度举行
  • 批准号:
    8257390
  • 财政年份:
    2011
  • 资助金额:
    $ 31.14万
  • 项目类别:
Tumor-cell-specific targets for combined hyperthermia and radiation effects
结合热疗和放射效应的肿瘤细胞特异性靶标
  • 批准号:
    8511582
  • 财政年份:
    2010
  • 资助金额:
    $ 31.14万
  • 项目类别:
Tumor-cell-specific targets for combined hyperthermia and radiation effects
结合热疗和放射效应的肿瘤细胞特异性靶标
  • 批准号:
    8134902
  • 财政年份:
    2010
  • 资助金额:
    $ 31.14万
  • 项目类别:
CHROMATIN MODIFYING FACTORS CONTROL RADIATION RESPONSE AND GENOMIC STABILITY
染色质修饰因子控制辐射反应和基因组稳定性
  • 批准号:
    8305606
  • 财政年份:
    2008
  • 资助金额:
    $ 31.14万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 31.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了